Published • loading... • Updated
Canada's Drug Agency recommends Zepbound for prediabetes - will this cut cost for Canadians?
Summary by Dr Sue
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Canada's Drug Agency recommends Zepbound for prediabetes - will this cut cost for Canadians?
Prediabetes is extremely common, affecting 14-37% of people with obesity (depending on the population studied and the criteria used to diagnose prediabetes and obesity) . About 25% of people with prediabetes will develop type 2 diabetes over 3-5 years. Several weight management medications have been shown to reduce risk of developing type 2 diabetes, or […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
